---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-034129"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T19:06:25.931820+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Longeveron raises $6.2M from warrant exercise, total $11.4M; regains Nasdaq compliance

## Summary
- Gross proceeds of ~$6.2M from exercise of 2,399,744 existing warrants at $2.35/share; combined with prior public offering totals ~$11.4M.
- Issued new unregistered warrants to purchase up to 4,799,488 shares (Series C: 5-year term, Series D: 24-month term, both at $2.35 exercise price).
- Intends to use net proceeds for clinical/regulatory development of Lomecel-B for HLHS, Alzheimer's, and general corporate purposes.
- Regained compliance with Nasdaq minimum bid price requirement after closing price >=$1.00 for 13 consecutive business days through April 15, 2024.

## SEC filing metadata
- accession: 0001213900-24-034129
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390024034129/0001213900-24-034129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390024034129/ea0204043-8k_longeve.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-034129
- JSON: https://secwatch.observer/filing/0001213900-24-034129.json
- Plain text: https://secwatch.observer/filing/0001213900-24-034129.txt

## Key facts
- Material Agreements
  Longeveron Inc. entered into Inducement Letter Agreements with certain holders valued at approximately $6.2 million (effective 2024-04-16).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain holders
  - Value: approximately $6.2 million
  - Effective: 2024-04-16
  source text: On April 16, 2024, Longeveron Inc., a Delaware corporation (the “Company”), entered into inducement letter agreements (the “Inducement Letter Agreements”) with certain holders (the “Holders”) of its existing (i) Series A warrants to purchase up to an aggregate of 242,425 shares of the Company’s Class A common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1721484/000121390024034129/0001213900-24-034129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.